Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Efficacy of rituximab in refractory neuromyelitis optica.
Treatment of neuromyelitis optica.
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
An update of teriflunomide for treatment of multiple sclerosis.
Altered tract-specific white matter microstructure is related to poorer cognitive performance: The Rotterdam Study.
Elevated CNS inflammation in patients with preclinical Alzheimer's disease.
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.
Robot-supported upper limb training in a virtual learning environment : a pilot randomized controlled trial in persons with MS.
Cancer specific risk in multiple sclerosis patients.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
CCRL2 regulates M1/M2 polarization during EAE recovery phase.
[Multiple sclerosis and microRNA].
Can people with multiple sclerosis actually understand what they read in the Internet age?
Oxidative stress in multiple sclerosis: Central and peripheral mode of action.
Inverse Correlation of Expression of miR-140-5p with Progression of Multiple Sclerosis and Differentiation of Encephalitogenic Th1 cells.
Tysabri may be option for kids with MS
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No.]
Evaluation of Rho-Kinase Activity in Mice Brain Using N-[(11)C]Methyl-hydroxyfasudil with Positron Emission Tomography.
Psoriasis and comorbidities. Epidemiological studies.
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
Dystonic pattern in a fibromyalgia patient: Relevance of a biopsychosocial rehabilitation approach.
Pages
« first
‹ previous
…
666
667
668
669
670
671
672
673
674
…
next ›
last »